These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8744936)

  • 1. Blood glucose levels in hypertensive patients during treatment with different antihypertensive agents.
    Ahaneku JE
    Acta Med Okayama; 1996 Apr; 50(2):107-10. PubMed ID: 8744936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure and blood glucose levels during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
    Ahaneku JE
    Kobe J Med Sci; 1996 Feb; 42(1):19-29. PubMed ID: 8984227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical changes during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
    Ahaneku JE; Taylor GO; Walker O; Agbedana EO; Sowunmi A; Salako LA
    J Pak Med Assoc; 1996 Apr; 46(4):71-3. PubMed ID: 8991356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically additive effect between doxazosin and amlodipine in the treatment of essential hypertension.
    Nalbantgil S; Nalbantgil I; Onder R
    Am J Hypertens; 2000 Aug; 13(8):921-6. PubMed ID: 10950401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in lipid and lipoprotein values during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
    Ahaneku JE; Taylor GO; Agbedana EO; Walker O; Salako LA
    J Pak Med Assoc; 1994 Jul; 44(7):166-9. PubMed ID: 7933456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatment of hypertension in acute intermittent porphyria: doxazosin and amlodipine.
    Gorchein A
    Br J Clin Pharmacol; 1997 Mar; 43(3):339-40. PubMed ID: 9088595
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
    Omvik P; Lund-Johansen P
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):193-206. PubMed ID: 8395198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Add-on effect of bedtime dosing of the alpha(1)-adrenergic receptor antagonist doxazosin on morning hypertension and left ventricular hypertrophy in patients undergoing long-term amlodipine monotherapy.
    Ikeda T; Gomi T; Shibuya Y; Shinozaki S; Suzuki Y; Matsuda N
    Hypertens Res; 2007 Nov; 30(11):1097-105. PubMed ID: 18250559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxazosin, but not amlodipine decreases insulin resistance in patients with chronic renal failure: a prospective, randomized-controlled study.
    Yildiz A; Hursit M; Celik AV; Kayacan SM; Yazici H; Akkaya V; Gürol AO; Karsidag K
    Clin Nephrol; 2002 Dec; 58(6):405-10. PubMed ID: 12508961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of doxazosin therapy on glucose tolerance and lipid metabolism in hypertensive patients with impaired glucose tolerance.
    Shionoiri H; Ashino K; Yamanaka K; Shindo K; Hiroto S; Arita T
    Clin Ther; 1997; 19(3):527-36. PubMed ID: 9220217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical usefulness of doxazosin in patients with type 2 diabetes complicated by hypertension: effects on glucose and lipid metabolism.
    Inukai T; Inukai Y; Matsutomo R; Okumura K; Takanashi K; Takebayashi K; Tayama K; Aso Y; Takemura Y
    J Int Med Res; 2004; 32(2):206-13. PubMed ID: 15080025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are all antihypertensive agents equal? Cardiovascular events in hypertensive patients randomized to treatment with doxazosin or chlorthalidone. The ALLHAT study].
    Schillaci G; Verdecchia P
    Ital Heart J Suppl; 2000 Sep; 1(9):1215-7. PubMed ID: 11140297
    [No Abstract]   [Full Text] [Related]  

  • 15. [Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy].
    Statsenko ME; Derevianchenko MV
    Ter Arkh; 2014; 86(8):90-3. PubMed ID: 25306751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
    Yilmaz MI; Sonmez A; Caglar K; Celik T; Yenicesu M; Eyileten T; Acikel C; Oguz Y; Yavuz I; Vural A
    Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertension and metabolic syndrome in population of one company. Monotherapy with amlodipine and doxazosin].
    Cybulski J; Ceremuzyński L
    Pol Merkur Lekarski; 2002 Jul; 13(73):43-7. PubMed ID: 12362505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of doxazosin on the size of LDL particle in the type 2 diabetic patients with hypertension.
    Tamasawa N; Matsui J; Ogawa Y; Gotoh T; Hinata T; Murakami H; Zhi GJ; Suda T
    J Diabetes Complications; 2000; 14(3):135-9. PubMed ID: 10989321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antihypertensive treatment with doxazosin on insulin sensitivity and fibrinolytic parameters.
    Zehetgruber M; Christ G; Gabriel H; Mundigler G; Beckmann R; Binder BR; Huber K
    Thromb Haemost; 1998 Feb; 79(2):378-82. PubMed ID: 9493594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.